Highbridge Capital Management’s Pernix Therapeutics Holdings, Inc. PTX Stock Holding History

Highbridge Capital Management’s Portfolio PTX Stock Details PTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-11,500	Closed	-$11K	–	593
2018 Q3	$11K	Buy	+11,500	New	+$19.2K	﹤0.01%	465
2016 Q1	–	Sell	-10,654	Closed	-$314K	–	2075
2015 Q4	$314K	Buy	+10,654	New	+$322K	﹤0.01%	1174
2015 Q3	–	Sell	-14,931	Closed	-$884K	–	2007
2015 Q2	$884K	Buy	+14,931	New	+$1.05M	0.01%	767

Other funds holding PTX

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Aisling Capital New York $45.3M AUM 15.24% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

MFGP

Marshall Financial Group (Pennsylvania) Doylestown, Pennsylvania $364M AUM 12.86% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Cetera Investment Advisers Schaumburg, Illinois $94B AUM 20.14% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Highbridge Capital Management's PTX Position: Q4 2018 in Review

Highbridge Capital Management sold out of Pernix Therapeutics Holdings, Inc. (PTX) in Q4 2018, closing a stake of 11,500 shares — an estimated $11K sold.

Highbridge Capital Management first reported a position in PTX in Q2 2015 and held it in 3 quarters. The position peaked at $884K in Q2 2015. 32 funds tracked by Wall St. Rank hold PTX as of Q4 2018.

Highbridge Capital Management reported no remaining Pernix Therapeutics Holdings, Inc. position as of Q4 2018 after selling out during the quarter.
Highbridge Capital Management sold 11,500 Pernix Therapeutics Holdings, Inc. shares in Q4 2018, an estimated $11K.
Highbridge Capital Management first reported a position in Pernix Therapeutics Holdings, Inc. in Q2 2015 and held it in 3 quarters.
Highbridge Capital Management's Pernix Therapeutics Holdings, Inc. position peaked at $884K in Q2 2015.
32 funds tracked by Wall St. Rank held Pernix Therapeutics Holdings, Inc. as of Q4 2018.

Based on Highbridge Capital Management's 13F filing for Q4 2018, filed 14 Feb 2019.